These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35260314)

  • 1. Association between KLF6 rs3750861 polymorphism and plasma ceramide concentrations in post-menopausal women with type 2 diabetes.
    Mantovani A; Zusi C; Lunardi G; Bonapace S; Lippi G; Maffeis C; Targher G
    Nutr Metab Cardiovasc Dis; 2022 May; 32(5):1283-1287. PubMed ID: 35260314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes.
    Mantovani A; Altomari A; Lunardi G; Bonapace S; Lippi G; Bonnet F; Targher G
    Diabetes Metab; 2020 Sep; 46(4):326-330. PubMed ID: 31185304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1 Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2 Diabetes.
    Mantovani A; Csermely A; Sani E; Beatrice G; Petracca G; Lunardi G; Bonapace S; Lippi G; Targher G
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between plasma ceramides and inducible myocardial ischemia in patients with established or suspected coronary artery disease undergoing myocardial perfusion scintigraphy.
    Mantovani A; Bonapace S; Lunardi G; Salgarello M; Dugo C; Canali G; Byrne CD; Gori S; Barbieri E; Targher G
    Metabolism; 2018 Aug; 85():305-312. PubMed ID: 29777715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease.
    Mantovani A; Lunardi G; Bonapace S; Dugo C; Altomari A; Molon G; Conti A; Bovo C; Laaksonen R; Byrne CD; Bonnet F; Targher G
    Diabetes Metab; 2021 Feb; 47(1):101152. PubMed ID: 32283179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography.
    Mantovani A; Bonapace S; Lunardi G; Canali G; Dugo C; Vinco G; Calabria S; Barbieri E; Laaksonen R; Bonnet F; Byrne CD; Targher G
    Diabetes Metab; 2020 Apr; 46(2):150-157. PubMed ID: 31386900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of urinary sphingolipids using liquid chromatography-tandem mass spectrometry in diabetic nephropathy.
    Morita Y; Kurano M; Sakai E; Nishikawa T; Nishikawa M; Sawabe M; Aoki J; Yatomi Y
    J Diabetes Investig; 2020 Mar; 11(2):441-449. PubMed ID: 31580528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between ceramides and coronary artery stenosis in patients with coronary artery disease.
    Tu C; Xie L; Wang Z; Zhang L; Wu H; Ni W; Li C; Li L; Zeng Y
    Lipids Health Dis; 2020 Jun; 19(1):151. PubMed ID: 32586390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method for quantifying hepatic and intestinal ceramides on mice by UPLC-MS/MS.
    Ge K; Zheng D; Wang J; Jia W; Zhao A
    Anal Biochem; 2023 Jan; 661():114982. PubMed ID: 36375519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between plasma ceramides and cardiovascular death in chronic heart failure: A subset analysis of the GISSI-HF trial.
    Targher G; Lunardi G; Mantovani A; Meessen J; Bonapace S; Temporelli PL; Nicolis E; Novelli D; Conti A; Tavazzi L; Maggioni AP; Latini R
    ESC Heart Fail; 2020 Dec; 7(6):3288-3297. PubMed ID: 32627354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a high-throughput LC-MS/MS assay for routine measurement of molecular ceramides.
    Kauhanen D; Sysi-Aho M; Koistinen KM; Laaksonen R; Sinisalo J; Ekroos K
    Anal Bioanal Chem; 2016 May; 408(13):3475-83. PubMed ID: 26922344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceramide stearic to palmitic acid ratio predicts incident diabetes.
    Hilvo M; Salonurmi T; Havulinna AS; Kauhanen D; Pedersen ER; Tell GS; Meyer K; Teeriniemi AM; Laatikainen T; Jousilahti P; Savolainen MJ; Nygård O; Salomaa V; Laaksonen R
    Diabetologia; 2018 Jun; 61(6):1424-1434. PubMed ID: 29546476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceramide ratios are affected by cigarette smoke but not heat-not-burn or e-vapor aerosols across four independent mouse studies.
    Lavrynenko O; Titz B; Dijon S; Santos DD; Nury C; Schneider T; Guedj E; Szostak J; Kondylis A; Phillips B; Ekroos K; Martin F; Peitsch MC; Hoeng J; Ivanov NV
    Life Sci; 2020 Dec; 263():118753. PubMed ID: 33189821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipidomic studies revealing serological markers associated with the occurrence of retinopathy in type 2 diabetes.
    He M; Hou G; Liu M; Peng Z; Guo H; Wang Y; Sui J; Liu H; Yin X; Zhang M; Chen Z; Rensen PCN; Lin L; Wang Y; Shi B
    J Transl Med; 2024 May; 22(1):448. PubMed ID: 38741137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma ceramides are associated with coronary atherosclerotic burden in patients with ST-segment elevation myocardial infarction.
    Pan W; Li L; Sun M; Wang C; Fang S; Yu B
    Int J Cardiol; 2020 Dec; 320():155-160. PubMed ID: 32800902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Plasma Ceramides With Myocardial Perfusion in Patients With Coronary Artery Disease Undergoing Stress Myocardial Perfusion Scintigraphy.
    Mantovani A; Bonapace S; Lunardi G; Salgarello M; Dugo C; Gori S; Barbieri E; Verlato G; Laaksonen R; Byrne CD; Targher G
    Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2854-2861. PubMed ID: 30571175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Ceramide: A New Cardiometabolic Biomarker in Patients With Comorbid Acute Coronary Syndrome and Type 2 Diabetes Mellitus.
    Cao R; Fang Z; Li S; Xu M; Zhang J; Han D; Hu W; Yan L; Wang Y; Fan L; Cao F
    Front Physiol; 2020; 11():1104. PubMed ID: 33041846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceramides and Cardiovascular Risk Factors, Inflammatory Parameters and Left Ventricular Function in AMI Patients.
    Michelucci E; Rocchiccioli S; Gaggini M; Ndreu R; Berti S; Vassalle C
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203637
    [No Abstract]   [Full Text] [Related]  

  • 19. Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes.
    Wretlind A; Curovic VR; Suvitaival T; Theilade S; Tofte N; Winther SA; Vilsbøll T; Vestergaard H; Rossing P; Legido-Quigley C
    Diabetes; 2023 Oct; 72(10):1493-1501. PubMed ID: 37478203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between elevated plasma ceramides and plaque rupture in patients with ST-segment elevation myocardial infarction.
    Pan W; Sun M; Wu J; Dong H; Liu J; Gao R; Fang S; Xing L; Hu S; Yu B
    Atherosclerosis; 2020 Jun; 302():8-14. PubMed ID: 32387714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.